Posts by tag
ALL
2 posts
Hematologic Oncology in Armenia: Progress, Bottlenecks, and What’s Next
In this article, we summarise a paper by Alisa Movsisyan et al., published in the OncoDaily Medical Journal, offering the first nationwide overview of hematologic oncology in Armenia, covering epidemiology, diagnostics, treatment, outcomes, and system gaps that shape care across…
CAR T cells v chemo for childhood leukaemia: are we ready for the next step?
Chimeric antigen receptor (CAR) T cells, genetically engineered immune cells targeted to attack cancers, are one of the most exciting breakthrough cancer treatments in oncology today. After decades of incremental development, its clinical efficacy was shown in 2010, with the…